Poster

MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that does not show signs of peripheral toxicity in preclinical models

Author
Kees Bol
Drug target
CD137xPD-L1
Drug moa
CD137 agonist and immune checkpoint inhibitor
Source url
s3://convoke-optic-posters/2024-05-10/P814-SITC-2020-MCLA-145-safety-poster_Submitted.pdf

3 organizations

1 product

Product
MCLA-145
Organization
Incyte
Organization
Merus NV
Organization
PD-value BV

Failed to display poster.